Microvention-terumo, Inc.
Clinical trials sponsored by Microvention-terumo, Inc., explained in plain language.
Medical device company specializing in neurovascular and endovascular therapies, owned by Terumo.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Brain aneurysm device under Long-Term scrutiny
Disease control OngoingThis study follows 195 adults who received the WEB device, a mesh implant used to block blood flow into wide-neck brain aneurysms. Researchers are checking how well the device works and its safety over one year. The goal is to confirm that the device remains a reliable option for…
Phase: NA • Sponsor: Microvention-Terumo, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New Stent-Like device aims to seal brain aneurysms without surgery
Disease control OngoingThis study is testing a device called FRED X, a small mesh tube placed inside an artery to block blood flow to a brain aneurysm. The goal is to see if it works as well as the earlier FRED device in preventing strokes and sealing the aneurysm. About 154 participants with a single …
Phase: NA • Sponsor: Microvention-Terumo, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Brain aneurysm device registry aims to improve patient outcomes
Knowledge-focused ENROLLING_BY_INVITATIONThis study is a registry that will collect real-world data from 750 people with brain aneurysms treated with MicroVention devices. The goal is to see how well these devices work and how safe they are in everyday medical practice. Participants will be followed for at least one yea…
Sponsor: Microvention-Terumo, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC